Neuronetics, Inc. is a private medical device company based in Malvern, PA. Neuronetics developed NeuroStar Transcranial Magnetic Stimulation (TMS) therapy, where magnetic fields are used for therapeutic applications in disorders related to central nervous system. In 2003, they licensed a revolutionary patented coil design from Emory University and conducted the largest clinical trials on TMS therapy to date. With continuous research and development, a high quality, efficient, user friendly and cost effective unit-NeuroStar TMS therapy system has been developed, for treating Major Depressive Disorder. TMS Therapy is a non-invasive, non-systemic computerized medical device that treats depression using a highly focused, pulsed magnetic field
…show more content…
Neuronetics was the first company to develop a non-systemic, non-invasive therapy targeting severe depression in people who have not responded to traditional depression treatments. Clinical trials began in 2007 and TMS became approved by the FDA in 2008. The company is expanding the therapies focus in new directions including: the treatment of epilepsy, depression in adolescents, ADHD (Attention Deficit Hyperactive Disorder), TS (Tourette’s Syndrome), Anxiety, OCD (Obsessive Compulsive Disorder), Schizophrenia, Headaches, and Traumatic Brain injuries …show more content…
Medical devices can range from the most simple thermometers to complex imaging systems such as magnetic resonance imaging (MRI). Neuromodulation is technology that acts upon nerves directly. It delivers electrical or pharmaceutical agents to a specific target area by altering the nerve activity. Neuromodulation devices and treatments are very effective (X). They treat nearly every disease like headaches to tremors to spinal cord damage to urinary incontinence. With a lot of scope and improvement in biotechnology, neuromodulation is poised as a major growth industry for the next decade. Neuromodulation has various applications, such as deep brain stimulation (DBS) treatment for Parkinson 's disease, sacral nerve stimulation for pelvic disorders and incontinence, and spinal cord stimulation for ischemic disorders (angina, peripheral vascular disease). Additionally, neuromodulation devices can stimulate a response where there was no response previously, as in the case of a cochlear implant restoring hearing in a deaf patient
Neuronetics was the first company to develop a non-systemic, non-invasive therapy targeting severe depression in people who have not responded to traditional depression treatments. Clinical trials began in 2007 and TMS became approved by the FDA in 2008. The company is expanding the therapies focus in new directions including: the treatment of epilepsy, depression in adolescents, ADHD (Attention Deficit Hyperactive Disorder), TS (Tourette’s Syndrome), Anxiety, OCD (Obsessive Compulsive Disorder), Schizophrenia, Headaches, and Traumatic Brain injuries …show more content…
Medical devices can range from the most simple thermometers to complex imaging systems such as magnetic resonance imaging (MRI). Neuromodulation is technology that acts upon nerves directly. It delivers electrical or pharmaceutical agents to a specific target area by altering the nerve activity. Neuromodulation devices and treatments are very effective (X). They treat nearly every disease like headaches to tremors to spinal cord damage to urinary incontinence. With a lot of scope and improvement in biotechnology, neuromodulation is poised as a major growth industry for the next decade. Neuromodulation has various applications, such as deep brain stimulation (DBS) treatment for Parkinson 's disease, sacral nerve stimulation for pelvic disorders and incontinence, and spinal cord stimulation for ischemic disorders (angina, peripheral vascular disease). Additionally, neuromodulation devices can stimulate a response where there was no response previously, as in the case of a cochlear implant restoring hearing in a deaf patient